Sláínte An Chláir is calling for an urgent overhaul of the approval process for European cancer medication in Ireland.
It follows a new report from the Irish Society of Medical Oncologists found that doctors are unable to prescribe the appropriate treatment to 25% of patients due to flaws within the HSE’s drug reimbursement procedure.
- Advertisement -
Currently, pharmaceutical companies must apply to the European Medicines Agency for a licence before they can seek restitution from the HSE, even if the drugs are already sanctioned for use in the EU.
Oncology Nurse with Sláínte An Chláír Anne Murphy says patients do not deserve to be left in the dark in the most difficult periods of their lives.
You can listen to the full interview below.
